Coffey RJ - Search Results

1

Intrathecal gabapentin to treat chronic intractable noncancer pain.

Rauck R, Coffey RJ, Schultz DM, Wallace MS, Webster LR, McCarville SE, Grigsby EJ, Page LM. Rauck R, et al. Among authors: coffey rj. Anesthesiology. 2013 Sep;119(3):675-86. doi: 10.1097/ALN.0b013e3182a10fbf. Anesthesiology. 2013. PMID: 23835590 Clinical Trial.

2

Inflammatory masses associated with intrathecal drug infusion: a review of preclinical evidence and human data.

Yaksh TL, Hassenbusch S, Burchiel K, Hildebrand KR, Page LM, Coffey RJ. Yaksh TL, et al. Among authors: coffey rj. Pain Med. 2002 Dec;3(4):300-12. doi: 10.1046/j.1526-4637.2002.02048.x. Pain Med. 2002. PMID: 15099235

3

Mortality associated with implantation and management of intrathecal opioid drug infusion systems to treat noncancer pain.

Coffey RJ, Owens ML, Broste SK, Dubois MY, Ferrante FM, Schultz DM, Stearns LJ, Turner MS. Coffey RJ, et al. Anesthesiology. 2009 Oct;111(4):881-91. doi: 10.1097/ALN.0b013e3181b64ab8. Anesthesiology. 2009. PMID: 20029253

4

Medical practice perspective: identification and mitigation of risk factors for mortality associated with intrathecal opioids for non-cancer pain.

Coffey RJ, Owens ML, Broste SK, Dubois MY, Ferrante FM, Schultz DM, Stearns LJ, Turner MS. Coffey RJ, et al. Pain Med. 2010 Jul;11(7):1001-9. doi: 10.1111/j.1526-4637.2010.00889.x. Pain Med. 2010. PMID: 20642729

5

Clinical accuracy and safety using the SynchroMed II intrathecal drug infusion pump.

Wesemann K, Coffey RJ, Wallace MS, Tan Y, Broste S, Buvanendran A. Wesemann K, et al. Among authors: coffey rj. Reg Anesth Pain Med. 2014 Jul-Aug;39(4):341-6. doi: 10.1097/AAP.0000000000000107. Reg Anesth Pain Med. 2014. PMID: 24956455 Free PMC article.

6

Management of intrathecal catheter-tip inflammatory masses: a consensus statement.

Hassenbusch S, Burchiel K, Coffey RJ, Cousins MJ, Deer T, Hahn MB, Pen SD, Follett KA, Krames E, Rogers JN, Sagher O, Staats PS, Wallace M, Willis KD. Hassenbusch S, et al. Among authors: coffey rj. Pain Med. 2002 Dec;3(4):313-23. doi: 10.1046/j.1526-4637.2002.02055.x. Pain Med. 2002. PMID: 15099236 Free article.

7

Prevention and management of intrathecal drug delivery and spinal cord stimulation system infections.

Follett KA, Boortz-Marx RL, Drake JM, DuPen S, Schneider SJ, Turner MS, Coffey RJ. Follett KA, et al. Among authors: coffey rj. Anesthesiology. 2004 Jun;100(6):1582-94. doi: 10.1097/00000542-200406000-00034. Anesthesiology. 2004. PMID: 15166581 Review. No abstract available.

8

Inflammatory mass lesions associated with intrathecal drug infusion catheters: report and observations on 41 patients.

Coffey RJ, Burchiel K. Coffey RJ, et al. Neurosurgery. 2002 Jan;50(1):78-86; discussion 86-7. doi: 10.1097/00006123-200201000-00014. Neurosurgery. 2002. PMID: 11844237

9

Abrupt withdrawal from intrathecal baclofen: recognition and management of a potentially life-threatening syndrome.

Coffey RJ, Edgar TS, Francisco GE, Graziani V, Meythaler JM, Ridgely PM, Sadiq SA, Turner MS. Coffey RJ, et al. Arch Phys Med Rehabil. 2002 Jun;83(6):735-41. doi: 10.1053/apmr.2002.32820. Arch Phys Med Rehabil. 2002. PMID: 12048649 Review.

10

Neurostimulation for chronic noncancer pain: an evaluation of the clinical evidence and recommendations for future trial designs.

Coffey RJ, Lozano AM. Coffey RJ, et al. J Neurosurg. 2006 Aug;105(2):175-89. doi: 10.3171/jns.2006.105.2.175. J Neurosurg. 2006. PMID: 17219820 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

515 results

Search Page

Filters